Security key
457637601
InMed Pharmaceuticals Inc. - Common Shares, no par value (INM)
CUSIP: 457637601
Q1 2024 13F Holders as of 31 Mar 2024
- Security type / class
- Equity / Common Shares, no par value
- Total 13F shares
- 685,852
- Total 13F value
- $249,191
- Share change
- -118,299
- SEC-reported price per share
- $0.36
- Number of holders
- 14
- Value change
- -$42,696
- Number of buys
- 5
- Number of sells
- 4
- Shares outstanding
- 804,525
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2024
Institutions
14
Top holders
10
INM full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2024
Previous quarter: Q4 2023
InMed Pharmaceuticals Inc. SEC filings
InMed Pharmaceuticals Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 457637601
Recent filing periods:
Ownership snapshot
Top reported holders of INM - InMed Pharmaceuticals Inc. - Common Shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
SABBY MANAGEMENT, LLC
Disclosed value leader
SABBY MANAGEMENT, LLC
Comparable rows
15/15
Latest evidence
31 Dec 2023
13F
Lead comparable stake: 64%
Showing 1-6 of 15 holder rows.
Quick read
SABBY MANAGEMENT, LLC leads the comparable SEC ownership view at 64%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens SABBY MANAGEMENT, LLC's linked filing trail.
Comparable ownership
Top 5
SABBY MANAGEMENT, LLC
64%
ARMISTICE CAPITAL, LLC
26%
RENAISSANCE TECHNOLOGIES LLC
4.8%
CITADEL ADVISORS LLC
4.2%
TWO SIGMA SECURITIES, LLC
1.6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| SABBY MANAGEMENT, LLC |
13F
Company
|
64%
|
$212,965
511,934 shares
|
— | 31 Dec 2023 |
| ARMISTICE CAPITAL, LLC |
13F
Company
|
26%
|
$85,683
205,968 shares
|
— | 31 Dec 2023 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
4.8%
|
$16,000
38,900 shares
|
— | 31 Dec 2023 |
| CITADEL ADVISORS LLC |
13F
Company
|
4.2%
|
$14,148
34,009 shares
|
— | 31 Dec 2023 |
| TWO SIGMA SECURITIES, LLC |
13F
Company
|
1.6%
|
$5,364
12,894 shares
|
— | 31 Dec 2023 |
| Qube Research & Technologies Ltd |
13F
Company
|
0.02%
|
$83
200 shares
|
— | 31 Dec 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
14
Shares
685,852
Rows available
14
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2024 vs Q4 2023 Across Filers
Q4 2023 holders
13
Q1 2024 holders
14
Holder diff
1
| Investor | Q4 2023 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q4 2023 value | Q1 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend